Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael P Johnson

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Bioorganic & Medicinal Chemistry Letters|July 7, 2012
Discovery and optimization of novel purines as potent and selective CB2 agonistsSean P Hollinshead, Peter C Astles, Mark G Chambers, et al.
Advances in Therapy|April 5, 2018
Impact of a Health Management Program on Healthcare Outcomes among Patients on Augmentation Therapy for Alpha 1-Antitrypsin Deficiency: An Insurance Claims AnalysisMichael A Campos, Michael C Runken, Angela M Davis, et al.
Patient Preference and Adherence|April 25, 2023
Palbociclib Adherence and Persistence in Patients with Hormone Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast CancerNicole M Engel-Nitz, Mary G Johnson, Michael P Johnson, et al.
Managed Care (Langhorne, Pa.)|September 13, 2017
Management of a Rare Disease Population: A Model for Identifying a Patient Population With Tuberous Sclerosis ComplexMichael P Johnson, Jonathan C Johnson, Nicole M Engel-Nitz, et al.
Journal of the American Medical Informatics Association : JAMIA|June 17, 2011
Handling anticipated exceptions in clinical care: investigating clinician use of 'exit strategies' in an electronic health records systemKai Zheng, David A Hanauer, Rema Padman, et al.
Cephalalgia : an International Journal of Headache|November 7, 2017
Human mast cells release the migraine-inducing factor pituitary adenylate cyclase-activating polypeptide (PACAP)Angela J Okragly, S Michelle Morin, David DeRosa, et al.
Patient Preference and Adherence|July 1, 2015
Patient-reported treatment satisfaction and choice of dosing frequency with biologic treatment for moderate to severe plaque psoriasisMingliang Zhang, Susan K Brenneman, Chureen T Carter, et al.
Annals of the New York Academy of Sciences|August 16, 2014
Clinical and economic outcomes of nutrition interventions across the continuum of careMarian de van der Schueren, Marinos Elia, Leah Gramlich, et al.
Journal of Medicinal Chemistry|June 26, 2013
Selective cannabinoid receptor type 2 (CB2) agonists: optimization of a series of purines leading to the identification of a clinical candidate for the treatment of osteoarthritic painSean P Hollinshead, Michael W Tidwell, John Palmer, et al.
Journal of Medicinal Chemistry|July 11, 2003
Discovery of allosteric potentiators for the metabotropic glutamate 2 receptor: synthesis and subtype selectivity of N-(4-(2-methoxyphenoxy)phenyl)-N-(2,2,2- trifluoroethylsulfonyl)pyrid-3-ylmethylamineMichael P Johnson, Melvyn Baez, G Erik Jagdmann, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry Letters|July 7, 2012
Discovery and optimization of novel purines as potent and selective CB2 agonistsSean P Hollinshead, Peter C Astles, Mark G Chambers, et al.
Advances in Therapy|April 5, 2018
Impact of a Health Management Program on Healthcare Outcomes among Patients on Augmentation Therapy for Alpha 1-Antitrypsin Deficiency: An Insurance Claims AnalysisMichael A Campos, Michael C Runken, Angela M Davis, et al.
Patient Preference and Adherence|April 25, 2023
Palbociclib Adherence and Persistence in Patients with Hormone Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast CancerNicole M Engel-Nitz, Mary G Johnson, Michael P Johnson, et al.
Managed Care (Langhorne, Pa.)|September 13, 2017
Management of a Rare Disease Population: A Model for Identifying a Patient Population With Tuberous Sclerosis ComplexMichael P Johnson, Jonathan C Johnson, Nicole M Engel-Nitz, et al.
Journal of the American Medical Informatics Association : JAMIA|June 17, 2011
Handling anticipated exceptions in clinical care: investigating clinician use of 'exit strategies' in an electronic health records systemKai Zheng, David A Hanauer, Rema Padman, et al.
Cephalalgia : an International Journal of Headache|November 7, 2017
Human mast cells release the migraine-inducing factor pituitary adenylate cyclase-activating polypeptide (PACAP)Angela J Okragly, S Michelle Morin, David DeRosa, et al.
Patient Preference and Adherence|July 1, 2015
Patient-reported treatment satisfaction and choice of dosing frequency with biologic treatment for moderate to severe plaque psoriasisMingliang Zhang, Susan K Brenneman, Chureen T Carter, et al.
Annals of the New York Academy of Sciences|August 16, 2014
Clinical and economic outcomes of nutrition interventions across the continuum of careMarian de van der Schueren, Marinos Elia, Leah Gramlich, et al.
Journal of Medicinal Chemistry|June 26, 2013
Selective cannabinoid receptor type 2 (CB2) agonists: optimization of a series of purines leading to the identification of a clinical candidate for the treatment of osteoarthritic painSean P Hollinshead, Michael W Tidwell, John Palmer, et al.
Journal of Medicinal Chemistry|July 11, 2003
Discovery of allosteric potentiators for the metabotropic glutamate 2 receptor: synthesis and subtype selectivity of N-(4-(2-methoxyphenoxy)phenyl)-N-(2,2,2- trifluoroethylsulfonyl)pyrid-3-ylmethylamineMichael P Johnson, Melvyn Baez, G Erik Jagdmann, et al.
Pageof 7